Claire Scott

Claire Scott (MacDonnell) has a wealth of experience in various leadership roles within the pharmaceutical industry. Claire currently serves as the Lifecycle Leader for Hemophilia Gene Therapy at Genentech, where Claire collaborates with SPARK Therapeutics to maximize the program's value. Claire has also held positions such as Vice President of Access Solutions and Patient Support, Senior Director of Access Solutions Operations, Franchise Head for Pulmozyme, and more. With a BA in International Relations from Saint Joseph's University, Claire's strategic and operational skills have greatly contributed to the success and growth of the organizations Claire has been a part of.